TranXenoGen Interim Results


SHREWSBURY, Mass., Sept. 5, 2002 (PRIMEZONE) -- TranXenoGen, Inc. ("TranXenoGen" or the "Company") (LSE:TXN), the avian transgenic company based in Shrewsbury, Massachusetts and listed on the Alternative Investment Market of the London Stock Exchange (TXN.L), today announced its interim operating results for the six months ended 30 June 2002.

To view the full press release, please click on the link: http://reports.huginonline.com/872734/107836.doc



            

Contact Data